368
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines

, , , , &
Pages 450-460 | Received 07 Feb 2005, Accepted 10 Aug 2005, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jie Deng, Lorne M Golub, Hsi-Ming Lee, Michael C Lin, Heta Dinesh Bhatt, Hou-Lin Hong, Francis Johnson, Joseph Scaduto, Thomas Zimmerman & Ying Gu. (2020) Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs. Journal of Experimental Pharmacology 12, pages 47-60.
Read now
B.L. Marcial, S.F. Sousa, H.F. Dos Santos & M.J. Ramos. (2014) Structural and dynamics analysis of matrix metalloproteinases MMP-2 complexed with chemically modified tetracyclines (CMTs). Journal of Biomolecular Structure and Dynamics 32:12, pages 1907-1918.
Read now
Takuya Nakajima, Keiichi Hishikari, Masahito Ogawa, Ryo Watanabe, Jun-ichi Suzuki, Ayako Nagashima, Mayumi Masumura, Kiyoshi Takayama, Yasunobu Hirata, Ryozo Nagai & Mitsuaki Isobe. (2010) Clarithromycin attenuates myocardial ischemia–reperfusion injury. Expert Opinion on Therapeutic Targets 14:9, pages 881-893.
Read now

Articles from other publishers (12)

Muhammad Tufail. (2023) Unlocking the potential of the tumor microenvironment for cancer therapy. Pathology - Research and Practice 251, pages 154846.
Crossref
Yuewen Gao, Zhengwu Pan, Hongqi Li & Fei Wang. (2023) Antitumor Therapy Targeting the Tumor Microenvironment. Journal of Oncology 2023, pages 1-16.
Crossref
Shilpi Goenka & Sanford R. Simon. (2021) Comparative study of doxycycline, sancycline, and 4-dedimethylamino sancycline (CMT-3) on epidermal melanogenesis. Archives of Dermatological Research 315:2, pages 249-257.
Crossref
Sanjib Das, Sk Abdul Amin & Tarun Jha. (2021) Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies. European Journal of Medicinal Chemistry 223, pages 113623.
Crossref
Susana Proença, Bernardo Antunes, Rita C. Guedes, Filipa Ramilo-Gomes, M. Fátima Cabral, Judite Costa, Ana S. Fernandes, Matilde Castro, Nuno G. Oliveira & Joana P. Miranda. (2019) Pyridine-Containing Macrocycles Display MMP-2/9 Inhibitory Activity and Distinct Effects on Migration and Invasion of 2D and 3D Breast Cancer Models. International Journal of Molecular Sciences 20:20, pages 5109.
Crossref
Catarina Roma-Rodrigues, Rita Mendes, Pedro Baptista & Alexandra Fernandes. (2019) Targeting Tumor Microenvironment for Cancer Therapy. International Journal of Molecular Sciences 20:4, pages 840.
Crossref
Lin Zhao, Jiaying Xu, Yang Jiao, Haichao Wang & Saijun Fan. (2014) Novel mechanisms involving chemically modified tetracycline 3 cytotoxicity. Anti-Cancer Drugs 25:10, pages 1165-1174.
Crossref
Satish Kumar, Glenn T. Clark & Raymond A. Dionne. 2012. Orofacial Pain. Orofacial Pain 145 150 .
Ying Gu, Hsi-Ming Lee, Sanford R. Simon & Lorne M. Golub. (2011) Chemically modified tetracycline-3 (CMT-3): A novel inhibitor of the serine proteinase, elastase. Pharmacological Research 64:6, pages 595-601.
Crossref
Ying Gu, Hsi-Ming Lee, Timo Sorsa, Sanford R. Simon & Lorne M. Golub. (2010) Doxycyline inhibits mononuclear cell-mediated connective tissue breakdown. FEMS Immunology & Medical Microbiology 58:2, pages 218-225.
Crossref
Jinger Xie, Ayyappan Nair & Terry W. Hermiston. (2008) A comparative study examining the cytotoxicity of inducible gene expression system ligands in different cell types. Toxicology in Vitro 22:1, pages 261-266.
Crossref
Jed F. Fisher & Shahriar Mobashery. (2006) Recent advances in MMP inhibitor design. Cancer and Metastasis Reviews 25:1, pages 115-136.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.